HE4 combined with MDCT imaging is a good marker in the evaluation of disease extension in advanced epithelial ovarian carcinoma

Cecilia Midulla, Lucia Manganaro, Flavia Longo, Valentina Viggiani, Luigi Frati, Teresa Granato, Emanuela Anastasi

Research output: Contribution to journalArticle

Abstract

The purpose of the study was to evaluate the expression of the biomarkers CA125 and HE4 combined with imaging, in patients with advanced epithelial ovarian cancer (EOC). Forty-six women with EOC were included in the study all affected with peritoneal carcinomatosis. Twenty-two of 46 patients (group I) had peritoneal carcinomatosis with small implants in single or in multiple sites (score 1); 24/46 patients (group II) had macro-nodular implants and omental thickening (score 2). High levels of CA125 (350 ± 11, mean ± SEM) have been observed in 21/22 patients of group I, and a similar value (370 ± 13) has been observed in all patients belonging to group II. HE4 positivity values (350 ± 9) have been observed in all group I patients, whereas all patients belonging to group II showed a higher value of HE4 (600 ± 12). Statistically significant differences were observed between the HE4 levels observed in group I patients in comparison with group II patients (p <0.0001). In addition, we expressed the extension of lymph nodal disease in three scores: L1-L2-L3, and a statistically significant correlation was observed between high HE4 levels and severity of lymph nodal disease L3 (p <0.0001). The availability of biomarkers, particularly HE4, together with sophisticated imaging techniques, strengthens the clinical relevance of this study, for the follow-up of patients with peritoneal carcinomatosis.

Original languageEnglish
Pages (from-to)1291-1298
Number of pages8
JournalTumor Biology
Volume33
Issue number5
DOIs
Publication statusPublished - Oct 2012

    Fingerprint

Keywords

  • Biomarkers
  • CA125
  • Carcinomatosis
  • HE4
  • Ovarian cancer

ASJC Scopus subject areas

  • Cancer Research

Cite this

Midulla, C., Manganaro, L., Longo, F., Viggiani, V., Frati, L., Granato, T., & Anastasi, E. (2012). HE4 combined with MDCT imaging is a good marker in the evaluation of disease extension in advanced epithelial ovarian carcinoma. Tumor Biology, 33(5), 1291-1298. https://doi.org/10.1007/s13277-012-0376-5